Ascendis Pharma A/S - ADR Financials

$267.76

up-down-arrow $-3.36 (-1.24%)

As on 04-Sep-2026 12:37EDT

Market cap

info icon

$16,261 Mln

Revenue (TTM)

info icon

$1,054 Mln

P/E Ratio

info icon

19

P/B Ratio

info icon

9.8

Div. Yield

info icon

0 %

Income Statement (€ Mln)

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Operating Revenue
1,054.37
691.71
363.64
266.72
51.17
7.78
Cost of Revenue
103.47
103.18
44.26
44.40
12.14
3.52
Gross Profit
950.90
588.53
319.38
222.32
39.04
4.26
Operating Expenses
841.45
719.42
598.15
677.86
600.85
456.05
Operating Profit (EBIT)
109.45
-130.89
-278.76
-455.54
-561.81
-451.79
Other Income
--
--
--
--
--
--
Profit before Tax
101.11
-204.26
-373.24
-474.14
-577.82
-383.94
Provision for Tax
-654.74
14.78
4.84
7.30
5.38
-0.37
Profit after Tax (Net Income)
755.85
-219.03
-378.08
-481.45
-583.19
-383.58
Minority Interest
--
--
--
--
--
--
Consolidated Profit
--
--
--
--
-583.19
-383.58

Liabilities (€ Mln)

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Shareholder's Funds
1,435.90
-162.75
-105.71
-145.70
263.35
883.64
Minority Interest
--
--
--
--
--
--
Non-Current Liabilities
384.48
395.83
377.34
234.78
109.61
100.93
Current Liabilities
464.70
1,068.94
907.86
736.51
716.78
100.36
Total Liabilities
2,749.77
1,302.02
1,179.50
825.59
1,089.74
1,084.92

Assets (€ Mln)

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Non-Current Assets
895.24
193.50
118.63
122.87
166.27
279.04
Current Assets
1,389.84
1,108.51
1,060.86
702.72
923.47
805.89
Total Assets
3,674.91
1,302.02
1,179.50
825.59
1,089.74
1,084.92
Total Debt*
449.89
871.41
856.62
743.06
617.57
209.92
Net Current Assets
--
39.59
153.00
505.38
752.20
705.53

Cashflow (€ Mln)

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Cash From Operating Activities
--
51.77
-306.20
-467.36
-495.70
-417.65
Cash Flow from Investing Activities
--
-8.15
6.88
286.47
61.73
-110.58
Cash from Financing Activities
--
34.89
443.93
134.29
396.77
351.39
Net Cash Inflow / Outflow
--
--
--
--
--
--

Financials Ratios

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Adjusted EPS (€) info
11.45
-3.57
-6.32
-8.50
-10.42
-7.12
Cash EPS (€) info
--
-3.28
-6.03
-8.17
-10.09
-6.84
Adjusted Book Value (€) info
--
--
--
--
4.70
16.41
Dividend per Share (€) info
--
--
--
--
--
--
Cash Flow per Share (€) info
--
0.84
-5.12
-8.26
-8.85
-7.76
Free Cash Flow per Share (€) info
--
0.71
-5.15
-8.30
-9.11
-8.21

Profitability Ratios

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
ROCE (%) info
--
-30.01
-56.08
-65.14
-59.07
-37.90
ROE (%) info
--
163.18
300.78
-818.43
-101.69
-44.54
ROA (%) info
26.53
-17.65
-37.71
-50.27
-53.64
-37.16
EBIT Margin (%) info
5.73
-18.33
-84.63
-161.25
-1,068.30
-4,886.00
Net Margin (%) info
71.69
-31.67
-103.97
-180.51
-1,139.63
-4,931.56
Cash Profit Margin (%) info
0.00
--
--
--
--
--

Growth Ratios

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Revenue Growth (%) info
114.85
0.90
0.36
4.21
5.58
0.12
EBIT Growth (%) info
136.39
58.80
28.45
21.33
-43.85
8.92
Net Profit Growth (%) info
378.76
42.07
21.47
17.45
-52.04
8.44
EPS Growth (%) info
353.27
0.44
0.26
0.18
-0.46
0.09
Book Value Growth (%) info
816.12
--
--
--
--
--

Solvency Ratios

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Debt to Equity info
--
-5.35
-8.10
-5.10
2.35
0.24
Short term debt to equity ratio info
0.05
-2.99
-4.65
-2.99
1.62
0.02
Current Ratio info
2.99
1.04
1.17
0.95
1.29
8.03
Quick Ratio info
2.32
0.76
0.84
0.67
1.11
7.28
Interest Coverage info
1.62
-1.64
-4.70
-9.76
-17.82
-97.17

Operating Efficiency Ratios

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Debtors to sales (%) info
21.25
22.79
45.73
13.45
23.27
28.28
Asset Turnover info
0.37
0.56
0.36
0.28
0.05
0.01
Receivable days info
--
85.52
101.52
32.72
50.35
60.74
Inventory Days info
--
1,056.70
2,081.92
1,397.01
3,100.85
3,908.84
Payable days info
--
331.01
787.97
804.62
2,414.27
4,215.15
Cash Conversion Cycle info
--
811.21
1,395.47
625.11
736.93
-245.57
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...